JPH1017455A - Agent for inhibiting activity of tyrosinase and cosmetic - Google Patents
Agent for inhibiting activity of tyrosinase and cosmeticInfo
- Publication number
- JPH1017455A JPH1017455A JP8173284A JP17328496A JPH1017455A JP H1017455 A JPH1017455 A JP H1017455A JP 8173284 A JP8173284 A JP 8173284A JP 17328496 A JP17328496 A JP 17328496A JP H1017455 A JPH1017455 A JP H1017455A
- Authority
- JP
- Japan
- Prior art keywords
- weight
- parts
- chlorophorin
- tyrosinase activity
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000003425 Tyrosinase Human genes 0.000 title claims abstract description 35
- 108060008724 Tyrosinase Proteins 0.000 title claims abstract description 35
- 239000002537 cosmetic Substances 0.000 title claims abstract description 23
- 230000002401 inhibitory effect Effects 0.000 title abstract description 16
- 239000003795 chemical substances by application Substances 0.000 title abstract description 12
- OEILZVSHVTYHKL-MZYNZGBKSA-N Chlorophorin Chemical compound C1=C(O)C(C/C=C(C)/CCC=C(C)C)=C(O)C=C1\C=C\C1=CC=C(O)C=C1O OEILZVSHVTYHKL-MZYNZGBKSA-N 0.000 claims abstract description 34
- OCFVFLARSYEAIK-UHFFFAOYSA-N Chlorophorin Natural products CC(=CCC(CC=C(C)C)c1c(O)cc(C=Cc2ccc(O)cc2O)cc1O)C OCFVFLARSYEAIK-UHFFFAOYSA-N 0.000 claims abstract description 34
- 230000000694 effects Effects 0.000 claims abstract description 31
- 239000004480 active ingredient Substances 0.000 claims abstract description 10
- 239000003112 inhibitor Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 abstract description 10
- 230000002087 whitening effect Effects 0.000 abstract description 8
- 239000002023 wood Substances 0.000 abstract description 6
- 239000003906 humectant Substances 0.000 abstract description 4
- 235000004607 Chlorophora excelsa Nutrition 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000013329 compounding Methods 0.000 abstract description 2
- 241000595436 Milicia excelsa Species 0.000 abstract 2
- 229920000877 Melamine resin Polymers 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000008213 purified water Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000006210 lotion Substances 0.000 description 10
- 230000008099 melanin synthesis Effects 0.000 description 10
- -1 thiol compounds Chemical class 0.000 description 10
- 238000002156 mixing Methods 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 241000218232 Artocarpus Species 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 206010014970 Ephelides Diseases 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- 208000003351 Melanosis Diseases 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 235000002672 Artocarpus altilis Nutrition 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 5
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 5
- 229960004705 kojic acid Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000004264 Petrolatum Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000012259 ether extract Substances 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 235000019271 petrolatum Nutrition 0.000 description 4
- 229940066842 petrolatum Drugs 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- 240000004161 Artocarpus altilis Species 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 201000001441 melanoma Diseases 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 241000218231 Moraceae Species 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000010265 fast atom bombardment Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- SWFHGTMLYIBPPA-UHFFFAOYSA-N (4-methoxyphenyl)-phenylmethanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 SWFHGTMLYIBPPA-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- NDNMXRYLRJEZAR-UHFFFAOYSA-N 2-[1-(4-methoxyphenyl)propylidene]octanoic acid Chemical compound CCCCCCC(C(O)=O)=C(CC)C1=CC=C(OC)C=C1 NDNMXRYLRJEZAR-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021509 Artocarpus incisus Nutrition 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 244000229769 Chlorophora excelsa Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000002628 heparin derivative Substances 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、皮膚のシミ、ソバ
カス等の予防又は治療に有効なチロシナーゼ活性阻害剤
及び該阻害剤を利用した化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a tyrosinase activity inhibitor effective for the prevention or treatment of skin spots, freckles and the like, and to a cosmetic using the inhibitor.
【0002】[0002]
【従来の技術】従来、皮膚のシミ、ソバカスの予防又は
治療を目的として、チロシナーゼ活性を阻害することに
よりメラニン生成を抑制する物質が種々提案されてい
る。具体的には、ビタミンC、ハイドロキノン、コウジ
酸、チオール系化合物、種々の動植物抽出物が知られて
おり、これらを配合する化粧料が開発され、商品化され
ている。しかし、前記ビタミンC、ハイドロキノン、コ
ウジ酸は極性が高いため、化粧料として配合するにはこ
の点を考慮する必要がある。また前記チオール系化合物
は、化粧料への配合にあたって安定性に問題がある。更
に従来提案されている動植物抽出物は、チロシナーゼ活
性阻害能が十分なものが少ないのが実状である。2. Description of the Related Art Conventionally, various substances have been proposed for inhibiting melanin production by inhibiting tyrosinase activity for the purpose of preventing or treating skin spots and freckles. Specifically, vitamin C, hydroquinone, kojic acid, thiol-based compounds, and various animal and plant extracts are known, and cosmetics containing these have been developed and commercialized. However, since vitamin C, hydroquinone, and kojic acid have high polarity, it is necessary to consider this point when blending as cosmetics. Further, the thiol-based compound has a problem in stability when blended into cosmetics. Furthermore, there are few animal and plant extracts that have been proposed so far that have sufficient tyrosinase activity inhibiting ability.
【0003】一方、クロロフォリンは、クワ科(Chloro
phora excelsa)の材に存在することが知られているが、
クロロフォリンがチロシナーゼ活性阻害能を有すること
については従来知られていない。On the other hand, chlorophorin is a mulberry family (Chloro
phora excelsa) is known to exist in the wood,
It has not been known that chlorophorin has the ability to inhibit tyrosinase activity.
【0004】[0004]
【発明が解決しようとする課題】従って本発明の目的
は、メラニン生成に関与するチロシナーゼ活性を強く抑
制するチロシナーゼ活性阻害剤を提供することにある。
本発明の別の目的は、チロシナーゼ活性を抑制すること
によりメラニン生成を抑制し、美白作用等を示す化粧料
を提供することにある。Accordingly, an object of the present invention is to provide a tyrosinase activity inhibitor which strongly suppresses tyrosinase activity involved in melanin production.
Another object of the present invention is to provide a cosmetic that suppresses tyrosinase activity to suppress melanin production and exhibits a whitening effect and the like.
【0005】[0005]
【課題を解決するための手段】本発明によれば、クロロ
フォリンを有効成分として含有するチロシナーゼ活性阻
害剤が提供される。また本発明によれば、前記チロシナ
ーゼ活性阻害剤を含む化粧料が提供される。According to the present invention, there is provided a tyrosinase activity inhibitor containing chlorophorin as an active ingredient. Further, according to the present invention, there is provided a cosmetic comprising the tyrosinase activity inhibitor.
【0006】[0006]
【発明の実施の形態】以下本発明を更に詳細に説明す
る。本発明のチロシナーゼ活性阻害剤は、下記構造式で
表されるクロロフォリンを有効成分とする。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in more detail. The tyrosinase activity inhibitor of the present invention contains chlorophorin represented by the following structural formula as an active ingredient.
【0007】[0007]
【化1】 Embedded image
【0008】クロロフォリンは、クワ科(Chlorophora
excelsa)の材に存在し、この材の粉末又は削り屑を温時
エーテル抽出し溶媒を除いてから再結晶して得られるこ
とが知られている。例えば、クワ科パンノキ属(Artocar
pus)に属するパンノキ(Artocarpus incisus)の溶媒抽出
物から精製単離することもできる。[0008] Chlorophorin is a mulberry family ( Chlorophora).
excelsa ) is known to be obtained by extracting the powder or shavings of this material with ether at a warm temperature, removing the solvent, and recrystallizing the material. For example, Artocar
pus ) can be purified and isolated from a solvent extract of breadfruit ( Artocarpus incisus ) belonging to the same species .
【0009】本発明のチロシナーゼ活性阻害剤は、前記
有効成分を含有しておれば良く、その含有割合は、0.
0001重量%以上である。The tyrosinase activity inhibitor of the present invention may contain the above-mentioned active ingredient.
0001% by weight or more.
【0010】本発明の化粧料は、前記チロシナーゼ活性
阻害剤を必須成分として含有し、好ましくはチロシナー
ゼ活性阻害作用に基づくメラニン生成抑制作用を示し、
美白化粧料とすることができる。前記チロシナーゼ活性
阻害剤の化粧料への配合割合は、有効成分であるクロロ
フォリンを0.0001重量%以上、特に0.0001
〜20重量%、更には0.0001〜10重量%である
のが望ましい。The cosmetic of the present invention contains the tyrosinase activity inhibitor as an essential component, and preferably exhibits a melanin production inhibitory action based on the tyrosinase activity inhibitory action,
It can be used as a whitening cosmetic. The compounding ratio of the tyrosinase activity inhibitor to the cosmetic is such that chlorophorin as an active ingredient is 0.0001% by weight or more, particularly 0.0001% by weight.
It is desirable that the content be 20 to 20% by weight, more preferably 0.0001 to 10% by weight.
【0011】本発明の化粧料には、前記チロシナーゼ活
性阻害剤の他に、その目的に応じて種々の材料を配合す
ることができる。特に従来公知の美白剤、しわ予防剤、
保湿剤又はこれらの混合物を配合することにより、所望
効果を相乗的に向上させることができる。[0011] In addition to the tyrosinase activity inhibitor, various materials can be added to the cosmetic of the present invention according to the purpose. Particularly conventionally known whitening agents, wrinkle preventives,
By blending a humectant or a mixture thereof, the desired effect can be synergistically improved.
【0012】前記美白剤としては、例えばコウジ酸、ア
スコルビン酸、ハイドロキノン、チオール系化合物、こ
れらの誘導体、これらを含有する動植物の抽出物又はこ
れらの混合物等を挙げることができる。前記保湿剤とし
ては、例えばグリセリン、プロピレングリコール、1,
3−ブチレングリコール、ソルビトール、マンニトー
ル、ポリエチレングリコール、ジプロピレングリコール
等の多価アルコール類;アミノ酸、乳酸ナトリウム、ピ
ロリドンカルボン酸ナトリウム等のNMF成分;ヒアル
ロン酸;コラーゲン;エラスチン;コンドロイチン硫
酸;フィブロネクチン;セラミド類;ヘパリン類似様物
質;キトサン等の水溶性高分子物質又はこれらの混合物
等を挙げることができる。前記美白剤、しわ防止剤又は
保湿剤を配合する際の配合割合は、好ましくは前記チロ
シナーゼ活性阻害剤の有効成分の0.001〜1000
倍量、特に好ましくは0.005〜500倍量の範囲で
配合するのが望ましい。Examples of the whitening agent include kojic acid, ascorbic acid, hydroquinone, thiol compounds, derivatives thereof, extracts of animals and plants containing them, and mixtures thereof. As the humectant, for example, glycerin, propylene glycol, 1,
Polyhydric alcohols such as 3-butylene glycol, sorbitol, mannitol, polyethylene glycol and dipropylene glycol; NMF components such as amino acids, sodium lactate and sodium pyrrolidone carboxylate; hyaluronic acid; collagen; elastin; chondroitin sulfate; fibronectin; ceramides A heparin-like substance; a water-soluble polymer substance such as chitosan; a mixture thereof; The blending ratio when blending the whitening agent, anti-wrinkle agent or humectant is preferably 0.001 to 1000 of the active ingredient of the tyrosinase activity inhibitor.
It is desirable to mix in a double amount, particularly preferably in a range of 0.005 to 500 times.
【0013】本発明の化粧料には、化粧類の種類に応じ
て一般に配合する油脂類、界面活性剤、アルコール類、
脂肪酸類、防腐剤、殺菌剤、増粘剤、酸化防止剤、色
素、香料、水溶性高分子、紫外線吸収剤、キレート剤、
pH調整剤、緩衝剤、精製水等の他の成分を適宜配合す
ることもできる。The cosmetics of the present invention include fats and oils, surfactants, alcohols, and the like generally incorporated according to the type of cosmetics.
Fatty acids, preservatives, bactericides, thickeners, antioxidants, pigments, fragrances, water-soluble polymers, ultraviolet absorbers, chelating agents,
Other components such as a pH adjuster, a buffer, and purified water can be appropriately blended.
【0014】前記増粘剤としては、アルギン酸ナトリウ
ム、キサンタンガム、ケイ酸アルミニウム、マルメロ種
子抽出物、トラガントガム、デンプン等の天然高分子物
質;メチルセルロース、可溶性デンプン、ヒドロキシエ
チルセルロース、カルボキシメチルセルロース、可溶性
デンプン、カチオン化セルロース等の半合成高分子物
質;カルボキシビニルポリマー、ポリビニルアルコール
等の合成高分子物質又はこれらの混合物等を挙げること
ができる。前記防腐剤としては、安息香酸塩、ソルビン
酸塩、ジヒドロ酢酸塩、パラオキシ安息香酸エステル、
2,2,4’−トリクロロ−2’−ヒドロキシジフェニ
ルエーテル、3,4,4’−トリクロロカルバニド、塩
化ベンザルコニウム、エタノール等を挙げることができ
る。前記酸化防止剤としては、ジブチルヒドロキシトル
エン、ブチルヒドロキシアニソール、ビタミンE、没食
子酸プロピル等を挙げることができる。前記紫外線吸収
剤としては、4−メトキシベンゾフェノン、オクチルジ
メチルパラアミノベンゾエート、エチルヘキシルパラメ
トキシサイナメート、酸化チタン、カオリン、タルク等
を挙げることができる。前記キレート剤としては、エチ
レンジアミン四酢酸塩、ピロリン酸塩、ヘキサメタリン
酸塩、クエン酸塩、酒石酸、グルコン酸等を挙げること
ができる。前記pH調整剤としては、水酸化ナトリウ
ム、リン酸水素カリウム、炭酸カリウム、クエン酸等を
挙げることができる。Examples of the thickener include sodium alginate, xanthan gum, aluminum silicate, quince seed extract, tragacanth gum, starch and other natural high molecular substances; methylcellulose, soluble starch, hydroxyethylcellulose, carboxymethylcellulose, soluble starch, cationized Semi-synthetic polymer substances such as cellulose; synthetic polymer substances such as carboxyvinyl polymer and polyvinyl alcohol; and mixtures thereof. As the preservative, benzoate, sorbate, dihydroacetate, p-hydroxybenzoate,
Examples thereof include 2,2,4'-trichloro-2'-hydroxydiphenyl ether, 3,4,4'-trichlorocarbanide, benzalkonium chloride, and ethanol. Examples of the antioxidant include dibutylhydroxytoluene, butylhydroxyanisole, vitamin E, propyl gallate and the like. Examples of the ultraviolet absorber include 4-methoxybenzophenone, octyldimethylparaaminobenzoate, ethylhexylparamethoxycinnamate, titanium oxide, kaolin, and talc. Examples of the chelating agent include ethylenediaminetetraacetate, pyrophosphate, hexametaphosphate, citrate, tartaric acid, gluconic acid and the like. Examples of the pH adjuster include sodium hydroxide, potassium hydrogen phosphate, potassium carbonate, citric acid and the like.
【0015】本発明の化粧料は、前記必須成分や必要に
応じて他の成分を、各種目的に応じて配合することによ
って、医薬品、医薬部外品又は化粧品として調製するこ
とができる。具体的にはローション、乳液、クリーム、
パック剤、皮膚洗浄剤、ハップ剤、プラスター剤、ペー
スト剤、軟膏、エッセンス、ゲル剤、シャンプー、リン
ス、パウダー、ファンデーション、化粧水、洗顔料、ヘ
アートニック、養毛剤、浴用剤等に調製することができ
る。この際他の成分は、前述の成分の他に、このような
各用途に従来使用されている成分を適宜選択して配合す
ることができる。The cosmetic of the present invention can be prepared as a drug, a quasi-drug, or a cosmetic by mixing the essential components and other components as necessary for various purposes. Specifically, lotions, emulsions, creams,
Packing agents, skin cleansing agents, haptics, plasters, pastes, ointments, essences, gels, shampoos, rinses, powders, foundations, lotions, facial cleansers, hair tonics, hair tonics, bath preparations, etc. it can. In this case, as the other components, in addition to the above-described components, components conventionally used for such applications can be appropriately selected and blended.
【0016】[0016]
【発明の効果】本発明のチロシナーゼ活性阻害剤は、食
用されているクワ科の材にもその存在が認められたクロ
ロフォリンを有効成分とするので、毒性がなく、メラニ
ン生成に関与するチロシナーゼ活性を強く抑制すること
ができる。また本発明の化粧料は、前記チロシナーゼ活
性阻害剤を必須成分として含有するので、チロシナーゼ
活性を抑制することによりメラニン生成を抑制し、美白
作用等が期待でき、しかも前記有効成分は、化粧料中に
安定に配合することができるので、広範囲に及ぶ各種化
粧料とすることができる。Industrial Applicability The tyrosinase activity inhibitor of the present invention has no toxicity and is not involved in tyrosinase activity involved in melanin production since chlorophorin, which is also found in edible mulberry wood, is used as an active ingredient. Can be strongly suppressed. In addition, the cosmetic of the present invention contains the tyrosinase activity inhibitor as an essential component, so that by suppressing tyrosinase activity, melanin production can be suppressed and a whitening effect can be expected, and the active ingredient is contained in the cosmetic. Can be stably compounded, so that various cosmetics can be obtained over a wide range.
【0017】[0017]
【実施例】以下、実施例により更に詳細に説明するが、
本発明はこれらに限定されるものではない。The present invention will be described in more detail with reference to the following examples.
The present invention is not limited to these.
【0018】実施例1 パンノキ(A.incisus)の木部37kgを粉砕機で細かく
粉砕してパンノキ材粉末を得た。得られたパンノキ材粉
末を、エーテルに浸漬し、室温で一昼夜保持した。次い
で、撹拌後、濾過してエーテル抽出液を得た。得られた
エーテル抽出液から溶媒及びアルトカルピン(artcarpi
n)を留去して母液とした。得られた母液を、HPLCで
数回処理して分画し、チロシナーゼ阻害活性を示す画分
を選択した。得られた活性画分に含有される化合物を、
LC−HRFABMS(liquid chromatography-high re
solution fast atom bombardment mass spectometry)に
より測定したところ、C24H28O4と推定され、更にN
MRにより分析したところクロロフォリンと同定した。
単離したクロロフォリンについて、以下に示すチロシナ
ーゼ活性阻害試験及びを行った。 Example 1 37 kg of wood of breadfruit (A. incisus) was finely ground with a grinder to obtain breadfruit powder. The obtained bread tree powder was immersed in ether and kept at room temperature for 24 hours. Then, after stirring, filtration was performed to obtain an ether extract. Solvent and altocarpine (artcarpi) were obtained from the obtained ether extract.
n) was distilled off to obtain a mother liquor. The obtained mother liquor was treated and fractionated by HPLC several times, and fractions showing tyrosinase inhibitory activity were selected. A compound contained in the obtained active fraction,
LC-HRFABMS (liquid chromatography-high re
solution fast atom bombardment mass spectometry), it was estimated to be C 24 H 28 O 4 ,
When analyzed by MR, it was identified as chlorophorin.
The isolated chlorophorin was subjected to the following tyrosinase activity inhibition test and the like.
【0019】チロシナーゼ活性阻害試験 0.1%L−チロシン溶液2.0ml(Mcilvaine 緩衝
液、pH6.8)、試料段階希釈液としてのクロロフォ
リンを含むジメチルスルフォキシド溶液0.2ml及び
マッシュルーム由来のチロシナーゼ(シグマ社製)12
50unit/ml緩衝液0.1mlを混合し、37℃
で10分間反応させた。次いで、475nmで吸光度を
測定し、コントロールに対するIC50を求めた。その結
果クロロフォリンのIC50は26ppbであり、公知の
チロシナーゼ阻害活性作用を示すコウジ酸(IC50=1
230ppb)の約47倍の活性があることがわかっ
た。 Tyrosinase activity inhibition test 2.0 ml of 0.1% L-tyrosine solution (Mcilvaine buffer, pH 6.8), 0.2 ml of dimethyl sulfoxide solution containing chlorophorin as a sample serial dilution, and mushroom-derived Tyrosinase (Sigma) 12
Mix 50 ml of 50 unit / ml buffer,
For 10 minutes. Then, the absorbance was measured at 475 nm to determine the IC 50 for the control. As a result, the IC 50 of chlorophorin was 26 ppb, indicating that kojic acid (IC 50 = 1) exhibiting a known tyrosinase inhibitory activity.
230 ppb).
【0020】B−16マウスメラノーマ細胞に対するメ
ラニン生成抑制試験 B−16マウスメラノーマ細胞を10%FBSを含むM
EM培地で1×105個/5mlに調整し、T−25フ
ラスコに5ml播種した。次いで5%CO2に調整した
CO2インキュベーターで37℃、24時間培養した。
細胞が完全に接着したことを確認し、ジメチルスルフォ
キシドに溶解した試料を最終濃度100ppmになるよ
うに添加した。培養期間は6日間とし、3日目に培地交
換した。培養終了後、トリプシン処理により細胞を回収
し、その白色化度及び細胞培養度を表1及び2の判定基
準に従って肉眼で判定した。結果を表3に示す。表3の
結果より、クロロフォリンにおいては細胞毒性がなく、
実用化に充分なメラニン生成抑制効果が得られた。[0020] A method for B-16 mouse melanoma cells
Lanin production inhibition test B-16 mouse melanoma cells were treated with M containing 10% FBS.
It was adjusted to 1 × 10 5 cells / 5ml in EM medium and 5ml seeded in T-25 flasks. Then, the cells were cultured at 37 ° C. for 24 hours in a CO 2 incubator adjusted to 5% CO 2 .
After confirming that the cells had completely adhered, a sample dissolved in dimethyl sulfoxide was added to a final concentration of 100 ppm. The culture period was 6 days, and the medium was replaced on the third day. After completion of the culture, the cells were collected by trypsin treatment, and the degree of whitening and the degree of cell culture were visually determined according to the criteria shown in Tables 1 and 2. Table 3 shows the results. From the results in Table 3, chlorophorin is not cytotoxic,
A melanin production inhibitory effect sufficient for practical use was obtained.
【0021】[0021]
【表1】 [Table 1]
【0022】[0022]
【表2】 [Table 2]
【0023】[0023]
【表3】 [Table 3]
【0024】モルモットを用いたメラニン生成抑制効果
試験 茶色モルモットの背部をバリカンで刈毛及び剃毛した。
次いで、1×1.5cmの長方形の穴を6箇所開けたア
ルミ箔で覆い、UV−Bランプ(商品名:FL40S・BLB(東
芝株式会社製)6本、2mW/cm2の強度で総照射量1
J/cm2)で1週間に3回の割合で照射し、2週間繰
返すことにより色素沈着を形成した。その後1週間は色
素沈着を安定化させるためにモルモットを放置した。4
週目から、1日1回、1週間に5回の割合で各試料1
2.5μlを色素沈着部位に連続4週間塗布した。塗布
前、塗布1、2、3週間後及び4週間後に、背部の写真
撮影を行った後、塗布前と塗布後の色彩色差を色彩色差
計(商品名:RC−100、ミノルタ社製)で測定し、
その差によりΔL値を算出して皮膚色の黒化判定を行っ
た。結果を表4に示す。表4の結果より、クロロフォリ
ンにおいてはメラニン生成を顕著に抑制することがわか
った。 Inhibitory effect of guinea pig on melanin production
The back of the test brown guinea pig was shaved and shaved with a clipper.
Next, cover a 1 × 1.5 cm rectangular hole with aluminum foil with six holes, and irradiate with UV-B lamps (trade name: FL40S / BLB (manufactured by Toshiba Corporation): 6, 2 mW / cm 2 in total). Quantity 1
(J / cm 2 ) three times a week and repeated for two weeks to form pigmentation. The guinea pigs were left for one week to stabilize pigmentation. 4
From the week, each sample 1 once a day, 5 times a week
2.5 μl was applied to the pigmented site for 4 consecutive weeks. Before application, 1, 2, 3 weeks and 4 weeks after application, the back was photographed, and the color difference before and after application was measured with a colorimeter (trade name: RC-100, manufactured by Minolta). Measure,
The ΔL value was calculated from the difference to determine the blackening of the skin color. Table 4 shows the results. From the results in Table 4, it was found that chlorophorin significantly suppressed melanin production.
【0025】[0025]
【表4】 [Table 4]
【0026】実施例2、比較例2 ステアリン酸4.0重量部、セチルアルコール3.0重
量部、ステアリルアルコール1.0重量部、流動パラフ
ィン6.5重量部、ワセリン10.0重量部、ソルビタ
ンモノステアレート1.5重量部及びポリオキシエチレ
ンモノステアレート(25E.O.)3.0重量部を加
熱溶解した。次いで、この加熱溶解溶液に、実施例1で
調製したクロロフォリン0.5重量部、1.3−ブチレ
ングリコール5.0重量部、水酸化カリウム0.1重量
部及び精製水65.4重量部を混合した後、冷却してク
リームを得た。また比較として、クロロフォリンを用い
ずに精製水の量を65.9重量部としたクリームを得
た。得られた各々のクリームを、20〜30歳の女性パ
ネル10人に朝と就寝前1日2回、1か月間使用させ、
その後の肌のシミ及びソバカス改善度を評価した。評価
は有効10点、やや有効5点、無効0点として肉眼判定
にて行った。その結果、実施例1で調製したクロロフォ
リンを配合した実施例2では平均7.0点、比較クリー
ムでは0点であった。 Example 2, Comparative Example 2 4.0 parts by weight of stearic acid, 3.0 parts by weight of cetyl alcohol, 1.0 part by weight of stearyl alcohol, 6.5 parts by weight of liquid paraffin, 10.0 parts by weight of petrolatum, sorbitan 1.5 parts by weight of monostearate and 3.0 parts by weight of polyoxyethylene monostearate (25EO) were dissolved by heating. Next, 0.5 parts by weight of chlorophorin prepared in Example 1, 5.0 parts by weight of 1.3-butylene glycol, 0.1 parts by weight of potassium hydroxide, and 65.4 parts by weight of purified water were added to the heat-dissolved solution. And then cooled to obtain a cream. For comparison, a cream was obtained in which the amount of purified water was 65.9 parts by weight without using chlorophorin. Each of the obtained creams was used by 10 female panels aged 20 to 30 years twice a day in the morning and before bedtime for one month,
Thereafter, the degree of improvement in skin spots and freckles was evaluated. The evaluation was made by visual judgment as effective 10 points, slightly effective 5 points, and invalid 0 points. As a result, the average score was 7.0 in Example 2 containing the chlorophorin prepared in Example 1, and 0 in the comparative cream.
【0027】実施例3、比較例3 実施例1で調製したクロロフォリン0.5重量部、ポリ
オキシエチレンセチルエーテル0.5重量部、プロピレ
ングリコール2.0重量部、1−メントール0.1重量
部及び精製水96.9重量部を均一に撹拌して化粧水を
得た。また比較として実施例1で調製したクロロフォリ
ンを用いずに精製水の量を97.4重量部とした化粧水
を得た。得られた各々の化粧水を、実施例2と同様にパ
ネル10人に使用させ、肌のシミ及びソバカス改善度を
同様に評価した。その結果、実施例1で調製したクロロ
フォリンを配合した実施例3では平均6.5点、比較化
粧水では0点であった。 Example 3, Comparative Example 3 0.5 parts by weight of chlorophorin, 0.5 parts by weight of polyoxyethylene cetyl ether, 2.0 parts by weight of propylene glycol, 0.1 part by weight of 1-menthol prepared in Example 1 Parts and 96.9 parts by weight of purified water were uniformly stirred to obtain a lotion. As a comparison, a lotion was obtained in which the amount of purified water was 97.4 parts by weight without using the chlorophorin prepared in Example 1. Each of the obtained lotions was used by 10 panelists in the same manner as in Example 2, and the degree of improvement in skin spots and freckles was similarly evaluated. As a result, the average was 6.5 points in Example 3 in which the chlorophorin prepared in Example 1 was blended, and 0 points in the comparative lotion.
【0028】実施例4、比較例4 実施例1で調製したクロロフォリン0.5重量部、ポリ
オキシエチレン硬化ヒマシ油(60E.O.)1.0重
量部、エタノール15.0重量部、1,3−ブチレング
リコール4.0重量部及び精製水79.5重量部を混合
撹拌し、各成分を溶解してローションを調製した。また
比較として実施例1で調製したクロロフォリンを用い
ず、精製水の量を80.0重量部としたローションを得
た。得られた各々のローションを、実施例2と同様にパ
ネル10人に使用させ、肌のシミ及びソバカス改善度を
同様に評価した。その結果、実施例1で調製したクロロ
フォリンを配合した実施例4では平均8.5点、比較ロ
ーションでは0点であった。 Example 4, Comparative Example 4 0.5 parts by weight of chlorophorin prepared in Example 1, 1.0 part by weight of polyoxyethylene hydrogenated castor oil (60EO), 15.0 parts by weight of ethanol, 1 part by weight , 3-butylene glycol 4.0 parts by weight and purified water 79.5 parts by weight were mixed and stirred, and each component was dissolved to prepare a lotion. As a comparison, a lotion was prepared in which the amount of purified water was 80.0 parts by weight without using the chlorophorin prepared in Example 1. Each of the obtained lotions was used by 10 panelists in the same manner as in Example 2, and the degree of improvement of skin spots and freckles was similarly evaluated. As a result, the average was 8.5 points in Example 4 containing the chlorophorin prepared in Example 1, and 0 points in the comparative lotion.
【0029】実施例5、比較例5 スクワラン8.0重量部、ワセリン2.0重量部、ミツ
ロウ0.5重量部、ソルビタンセスキオレート0.8重
量部及びポリオキシエチレンオレイルエーテル(20
E.O.)1.2重量部を加熱溶解した。得られた加熱
溶解溶液に、実施例1で調製したクロロフォリン0.5
重量部、カルボキシビニルポリマー0.2重量部、プロ
ピレングリコール5.0重量部、水酸化カリウム0.1
重量部、エタノール2.0重量部及び精製水79.7重
量部を混合した後、冷却して乳液を調製した。また比較
として実施例1で調製したクロロフォリンを用いず、精
製水の量を80.2重量部とした乳液を得た。得られた
各々の乳液を、実施例2と同様にパネル10人に使用さ
せ、肌のシミ及びソバカス改善度を同様に評価した。そ
の結果、実施例1で調製したクロロフォリンを配合した
実施例5では平均7.0点、比較乳液では0点であっ
た。 Example 5, Comparative Example 5 8.0 parts by weight of squalane, 2.0 parts by weight of petrolatum, 0.5 parts by weight of beeswax, 0.8 parts by weight of sorbitan sesquiolate and polyoxyethylene oleyl ether (20 parts by weight)
E. FIG. O. ) 1.2 parts by weight were dissolved by heating. The chlorophorin 0.5 prepared in Example 1 was added to the obtained heat-dissolved solution.
Parts by weight, carboxyvinyl polymer 0.2 parts by weight, propylene glycol 5.0 parts by weight, potassium hydroxide 0.1
After mixing 2.0 parts by weight of ethanol, 2.0 parts by weight of ethanol and 79.7 parts by weight of purified water, the mixture was cooled to prepare an emulsion. For comparison, an emulsion was prepared without using the chlorophorin prepared in Example 1 and using 80.2 parts by weight of purified water. Each of the obtained emulsions was used by 10 panelists in the same manner as in Example 2, and the degree of improvement in skin spots and freckles was similarly evaluated. As a result, the average was 7.0 in Example 5 containing the chlorophorin prepared in Example 1, and 0 in the comparative emulsion.
【0030】実施例6 スクワラン8.0重量部、ワセリン2.0重量部、ミツ
ロウ0.5重量部、ソルビタンセスキオレート0.8重
量部及びポリオキシエチレンオレイルエーテル(20
E.O.)1.2重量部を加熱溶解した。得られた加熱
溶解溶液に、実施例1で調製したクロロフォリン0.5
重量部、カルボキシビニルポリマー0.2重量部、プロ
ピレングリコール5.0重量部、水酸化カリウム0.1
重量部、エタノール2.0重量部、コウジ酸1.0重量
部及び精製水78.7重量部を混合した後、冷却して乳
液を調製した。 Example 6 8.0 parts by weight of squalane, 2.0 parts by weight of petrolatum, 0.5 parts by weight of beeswax, 0.8 parts by weight of sorbitan sesquiolate and polyoxyethylene oleyl ether (20 parts by weight)
E. FIG. O. ) 1.2 parts by weight were dissolved by heating. The chlorophorin 0.5 prepared in Example 1 was added to the obtained heat-dissolved solution.
Parts by weight, carboxyvinyl polymer 0.2 parts by weight, propylene glycol 5.0 parts by weight, potassium hydroxide 0.1
After mixing 2.0 parts by weight of ethanol, 2.0 parts by weight of ethanol, 1.0 part by weight of kojic acid and 78.7 parts by weight of purified water, the mixture was cooled to prepare an emulsion.
【0031】実施例7 モノステアリン酸ポリエチレングリコール1.0重量
部、親油型モノステアリン酸グリセリン2.0重量部、
オリーブ油5.0重量部、オレイン酸2.0重量部を加
熱溶解した。得られた加熱溶解溶液に、実施例1で調製
したクロロフォリン0.5重量部、ヒドロキシエチルセ
ルロース0.2重量部、プロピレングリコール2.0重
量部、グリチルリチン酸ジカリウム0.1重量部及び精
製水87.2重量部を混合した後、冷却して乳液を調製
した。 Example 7 1.0 part by weight of polyethylene glycol monostearate, 2.0 parts by weight of lipophilic glyceryl monostearate,
5.0 parts by weight of olive oil and 2.0 parts by weight of oleic acid were dissolved by heating. 0.5 part by weight of chlorophorin prepared in Example 1, 0.2 part by weight of hydroxyethyl cellulose, 2.0 parts by weight of propylene glycol, 0.1 part by weight of dipotassium glycyrrhizinate and purified water 87 were added to the obtained heat-dissolved solution. After mixing 2 parts by weight, the mixture was cooled to prepare an emulsion.
【0032】実施例8 ステアリン酸4.0重量部、セチルアルコール3.0重
量部、ステアリルアルコール1.0重量部、流動パラフ
ィン6.5重量部、ワセリン10.0重量部、ソルビタ
ンモノステアレート1.5重量部及びポリオキシエチレ
ンモノステアレート(25E.O.)3.0重量部を加
熱溶解した。次いで、この加熱溶解溶液に、実施例1で
調製したクロロフォリン0.5重量部、1.3−ブチレ
ングリコール5.0重量部、水酸化カリウム0.1重量
部、アルブチン0.2重量部及び精製水65.2重量部
を混合した後、冷却してクリームを得た。 Example 8 4.0 parts by weight of stearic acid, 3.0 parts by weight of cetyl alcohol, 1.0 part by weight of stearyl alcohol, 6.5 parts by weight of liquid paraffin, 10.0 parts by weight of petrolatum, sorbitan monostearate 1 0.5 parts by weight and 3.0 parts by weight of polyoxyethylene monostearate (25EO) were dissolved by heating. Next, 0.5 parts by weight of the chlorophorin prepared in Example 1, 5.0 parts by weight of 1.3-butylene glycol, 0.1 parts by weight of potassium hydroxide, 0.2 parts by weight of arbutin and After mixing 65.2 parts by weight of purified water, the mixture was cooled to obtain a cream.
─────────────────────────────────────────────────────
────────────────────────────────────────────────── ───
【手続補正書】[Procedure amendment]
【提出日】平成9年8月13日[Submission date] August 13, 1997
【手続補正1】[Procedure amendment 1]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0018[Correction target item name] 0018
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【0018】実施例1 パンノキ(A.incisus)の木部37kgを粉砕機で細かく
粉砕してパンノキ材粉末を得た。得られたパンノキ材粉
末を、エーテルに浸漬し、室温で一昼夜保持した。次い
で、撹拌後、濾過してエーテル抽出液を得た。得られた
エーテル抽出液から溶媒及びアルトカルピン(artcarpi
n)を留去して母液とした。得られた母液を、HPLCで
数回処理して分画し、チロシナーゼ阻害活性を示す画分
を選択した。得られた活性画分に含有される化合物を、
LC−HRFABMS(liquid chromatography-high re
solution fast atom bombardment mass spectometry)に
より測定したところ、C24H28O4と推定され、更にN
MRにより分析したところクロロフォリンと同定した。
単離したクロロフォリンについて、以下に示すチロシナ
ーゼ活性阻害試験、B−16マウスメラノーマ細胞に対
するメラニン生成抑制試験及びモルモットを用いたメラ
ニン生成抑制効果試験を行った。 Example 1 37 kg of wood of breadfruit (A. incisus) was finely ground with a grinder to obtain breadfruit powder. The obtained bread tree powder was immersed in ether and kept at room temperature for 24 hours. Then, after stirring, filtration was performed to obtain an ether extract. Solvent and altocarpine (artcarpi) were obtained from the obtained ether extract.
n) was distilled off to obtain a mother liquor. The obtained mother liquor was treated and fractionated by HPLC several times, and fractions showing tyrosinase inhibitory activity were selected. A compound contained in the obtained active fraction,
LC-HRFABMS (liquid chromatography-high re
solution fast atom bombardment mass spectometry), it was estimated to be C 24 H 28 O 4 ,
When analyzed by MR, it was identified as chlorophorin.
For the isolated chlorophorin, the following tyrosinase activity inhibition test was performed on B-16 mouse melanoma cells.
Melanin production inhibition test and mela using guinea pig
A nin production suppression effect test was performed.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 35/78 AED A61K 35/78 AEDD (72)発明者 柿野 賢一 福岡県福岡市博多区諸岡2丁目13−38 大 和コーポ305号 (72)発明者 佐藤 宏晶 福岡県大野城市山田3−1−25 原田荘 202 (72)発明者 長福 博志 福岡県筑紫野市筑紫駅前通1−10 シティ ハイム筑紫312──────────────────────────────────────────────────続 き Continuation of the front page (51) Int.Cl. 6 Identification code Agency reference number FI Technical display location A61K 35/78 AED A61K 35/78 AEDD (72) Inventor Kenichi Kakino 2 Moroka, Hakata-ku, Fukuoka City, Fukuoka Prefecture Chome 13-38 Daiwa Corp. No. 305 (72) Inventor Hiroaki Sato 3-1-25 Haradaso 202-3, Yamada, Onojo-shi, Fukuoka Prefecture (72) Inventor Hiroshi Nagafuku 1-10 Chikushi Ekimae-dori, Chikushino-shi, Fukuoka Prefecture City Heim Chikushi 312
Claims (2)
るチロシナーゼ活性阻害剤。1. A tyrosinase activity inhibitor comprising chlorophorin as an active ingredient.
を含む化粧料。2. A cosmetic comprising the tyrosinase activity inhibitor according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8173284A JP3023543B2 (en) | 1996-07-03 | 1996-07-03 | Tyrosinase activity inhibitor and cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8173284A JP3023543B2 (en) | 1996-07-03 | 1996-07-03 | Tyrosinase activity inhibitor and cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH1017455A true JPH1017455A (en) | 1998-01-20 |
JP3023543B2 JP3023543B2 (en) | 2000-03-21 |
Family
ID=15957604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8173284A Expired - Lifetime JP3023543B2 (en) | 1996-07-03 | 1996-07-03 | Tyrosinase activity inhibitor and cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3023543B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000045782A1 (en) * | 1999-02-02 | 2000-08-10 | Kansai Koso Co., Ltd. | TESTOSTERONE-5α-REDUCTASE INHIBITORS, HAIR GROWTH STIMULANT/HAIR NOURISHMENT COMPOSITIONS AND COMPOSITIONS FOR WHITENING COSMETICS |
FR2789898A1 (en) * | 1999-02-18 | 2000-08-25 | Oreal | The use of an extract of Chlorophora having a deodorant and antimicrobial action, in cosmetic and dermatological compositions |
WO2003009807A3 (en) * | 2001-07-23 | 2004-04-29 | Galileo Lab Inc | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
JP6407473B1 (en) * | 2017-07-27 | 2018-10-17 | 三菱電機株式会社 | High frequency mixer |
-
1996
- 1996-07-03 JP JP8173284A patent/JP3023543B2/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000045782A1 (en) * | 1999-02-02 | 2000-08-10 | Kansai Koso Co., Ltd. | TESTOSTERONE-5α-REDUCTASE INHIBITORS, HAIR GROWTH STIMULANT/HAIR NOURISHMENT COMPOSITIONS AND COMPOSITIONS FOR WHITENING COSMETICS |
FR2789898A1 (en) * | 1999-02-18 | 2000-08-25 | Oreal | The use of an extract of Chlorophora having a deodorant and antimicrobial action, in cosmetic and dermatological compositions |
WO2003009807A3 (en) * | 2001-07-23 | 2004-04-29 | Galileo Lab Inc | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
US7629375B2 (en) | 2001-07-23 | 2009-12-08 | Johnson & Johnson Consumer Companies, Inc. | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
JP6407473B1 (en) * | 2017-07-27 | 2018-10-17 | 三菱電機株式会社 | High frequency mixer |
Also Published As
Publication number | Publication date |
---|---|
JP3023543B2 (en) | 2000-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000095663A (en) | Agent for external use containing plant extract | |
JP2003300858A (en) | Skin care preparation | |
JPH10101543A (en) | Tyrosinase-activity inhibitor, and cosmetic | |
JPH05301811A (en) | Beautifying and whitening cosmetic | |
JP2003048846A (en) | Collagenase inhibitor and antiaging cosmetic | |
JPH06128121A (en) | Cosmetic | |
JP2003055190A (en) | Collagenase inhibitor and anti-ageing cosmetic | |
JPH11255639A (en) | Tyrosinase activity inhibitor and cosmetic | |
JPH11255638A (en) | Tyrosinase activity inhibitor and cosmetic | |
JPH11255637A (en) | Tyrosinase activity inhibitor and cosmetic | |
JPH1072330A (en) | Tyrosinase activity inhibitor and cosmetic | |
JP4244093B2 (en) | Whitening cosmetics | |
JPH0532533A (en) | Cosmetic | |
JP2003048812A (en) | Elastase inhibitor and antiaging cosmetic | |
JP3023543B2 (en) | Tyrosinase activity inhibitor and cosmetic | |
JP2001335472A (en) | Tyrosinase activity inhibitor and cosmetic | |
JP2006169225A (en) | External agent for preventing skin aging | |
JPH05194175A (en) | Cosmetic | |
JP2001131031A (en) | Composition for scalp and hair | |
JP2008094799A (en) | Sulfated glycosaminoglycan production promoter and external preparation for skin containing the same | |
KR20190061236A (en) | A cosmetic composition having excellent skin whitening and improving skin color effect | |
JPH05301812A (en) | Skin external preparation | |
JPH11292752A (en) | Beautifully whitening agent and composition for external use for skin | |
JPH08198741A (en) | Biological hyarulonic acid synthesis promoter | |
JP2000212057A (en) | Cosmetic composition |